TxaTech

TXA Tech is a biotechnology company focused on developing innovative delivery systems for Tranexamic Acid (TXA) to address life-threatening bleeding conditions. The company's primary mission is to reduce maternal mortality and trauma-related deaths by providing rapid, stable, and easy-to-administer formulations of TXA, particularly in low-resource settings. Their technology aims to overcome the limitations of current intravenous TXA administration, which requires refrigeration and skilled medical personnel. By engineering novel delivery mechanisms, TXA Tech seeks to make this essential medicine more accessible for postpartum hemorrhage and emergency trauma care globally.